Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences

Autor:	Ahmet Taner Sümbül, Osman Kostek, Deniz Tural, Fatma Paksoy Turkoz, Şeyda Gündüz, Mehmet Artac, Ömer Fatih Ölmez, Mustafa Yildirim, Dilek Erdem, Ali Osman Kaya, Yuksel Urun, Meltem Ekenel, Birol Yildiz, Ali Alkan, Emre Akar, Nail Özhan, Halil Taskaynatan, Özge Keskin, Mehmet Ali Nahit Sendur, Deniz Tataroğlu Özyükseler, Zuhat Urakci, Nail Paksoy, Ozgur Tanriverdi, Sabri Güncan, Ugur Yilmaz, Irem Bilgetekin, Elif Atag, Kerem Oruc, Mustafa Erman, Meltem Selam, Hasan Şenol Coşkun, Ahmet Dirican, Müge Sönmez, Tugba Basoglu, Selami Bayram, Burcu Çakar, Fatih Selcukbiricik, Semra Paydas, Saadettin Kilickap
Přispěvatelé:	Dicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radyasyon Onkolojisi Ana Bilim Dalı, Urakçı, Zuhat, Ege Üniversitesi
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty Urologic Neoplasms Metastatic Urothelial Carcinoma Survival Urology education 030232 urology & nephrology Antibodies Monoclonal Humanized Trial 03 medical and health sciences 0302 clinical medicine Atezolizumab Internal medicine medicine Clinical endpoint Humans Adverse effect Multicenter reproductive and urinary physiology health care economics and organizations Retrospective Studies Carcinoma Transitional Cell Bladder cancer business.industry medicine.disease Chemotherapy regimen humanities Clinical trial Urinary Bladder Neoplasms 030220 oncology & carcinogenesis Expanded access Urothelial carcinoma Therapy Immunotherapy Cisplatin Plus business
DOI:	10.1016/j.euf.2020.09.010
Popis:	[No abstract available] Amer Soc Clin Oncol
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dc593e73ea82bc330c89132a0963f04 https://doi.org/10.1016/j.euf.2020.09.010 Zobrazit plný text záznamu